醫藥活性成分市場：依產品類型、分子類型、劑型、應用及地區分類

Active Pharmaceutical Ingredients Market, By Product Type, By Molecular Type, By Formulation, By Application, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年，活性藥物成分（API）市場規模預計為2868.1億美元，預計2033年將達到4,605.6億美元。預計2026年至2033年，該市場將以7.0%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	2868.1億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.00%	2033年市場規模預測：	4605.6億美元

活性藥物成分（API）和輔料是製藥生產中最重要的兩個組成部分。 API是藥品生產中使用的原料，而輔料則是作為介質幫助藥物在體內吸收的物質，例如片劑中的乳糖或礦物油。活性藥物成分的生產貫穿研發和商業化生產的各個階段，均需採用高度技術化的工業流程。這些化合物的研發旨在發揮藥理作用，直接影響疾病的診斷、治療、緩解、復健和預防，或改變人體的結構和功能。活性藥物成分（API）市場的成長歸因於某些因素，包括各國政府加大對API的舉措。例如，2021年5月，美國衛生與公眾服務部（HHS）宣布與製藥公司Phlow Corporation簽署一項價值3.54億美元的四年期契約，用於生產治療新冠肺炎及相關疾病所需的活性藥物成分（API）。

市場動態

預計在預測期內，美國食品藥物管理局(FDA) 對製藥公司新藥的核准數量不斷增加，將進一步推動全球活性藥物成分 (API) 市場的成長。例如，2021 年 12 月，禮來公司 (Eli Lilly) 的多款藥物獲得 FDA 批准，其中包括用於治療 2 型糖尿病的 Trulicity 的劑量增加；用於治療核准腎小球濾過率 (eGFR) 突變陽性非小細胞肺癌的CYRAMZA；以及用於治療阿茲海默症患者的 tauvid。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球活性藥物成分 (API) 市場主要參與者的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球醫藥原料藥（API）市場報告針對行業內的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球活性藥物成分 (API) 市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

公司簡介
- Teva Pharmaceutical Industries Ltd
- Pfizer, Inc.
- Dr. Reddy's Laboratories Ltd
- Novartis AG
- Mylan NV
- Amneal Pharmaceuticals LLC
- Lonza Group
- Lupin Limited
- Fresenius Kabi
- Hikma Pharmaceuticals
- Cipla Limited
- Glenmark Pharmaceuticals Limited
- Sun Pharmaceutical Industries Ltd
- Endo International plc
- Aurobindo Pharma Limited
- Apotex Inc.
- Taro Pharmaceutical Industries Ltd
- Stada Arzneimittel AG
- Krka Pharmaceuticals
- CordenPharma International
- Evonik Industries AG
- Biological E. Limited

第10章

參考
調查方法

簡介目錄

Product Code: CMI738

Active Pharmaceutical Ingredients Market is estimated to be valued at USD 286.81 Bn in 2026 and is expected to reach USD 460.56 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 286.81 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.00%	2033 Value Projection:	USD 460.56 Bn

Active pharmaceutical ingredients (APIs) and excipients are the two most important components in the production of a medication. API is the raw material, which is used in manufacturing medications, whereas excipient is a substance that functions as a medium to help the body absorb the drug such as lactose or mineral oil in a tablet. Active pharmaceutical ingredients are produced by using highly technological industrial processes, both during the research & development and commercial production phases. Such compounds are developed to provide pharmacological activity or other direct impacts on disease diagnosis, cure, mitigation, therapy, or prevention, or to change the structure and function of the body. The growth of active pharmaceutical ingredient (API) market can be attributed to certain factors such as increasing funding initiatives by the government across different regions. For instance, in May 2021, the U.S. Department of Health and Human Services (HHS) announced that it will provide a funding of US$ 354 million to Phlow Corporation, a pharmaceutical company, under a four-year contract to produce the active pharmaceutical ingredients (APIs) needed for medications to treat patients with COVID-19 and related illnesses.

Market Dynamics

The rising U.S Food & Drug Administration (FDA) approvals for drugs by pharmaceutical companies is further expected to boost the global active pharmaceutical ingredient (API) market growth during the forecast period. For instance, in December 2021, Eily Lilly received the U.S FDA clearance for several medicines including increased dosages of its Trulicity therapy for the treatment of type 2 diabetes, Cyramza for the treatment of metastatic Estimated Glomerular Filteration Rate (EGFR)-mutated non-small cell lung cancer, and tauvid for individuals diagnosed with Alzheimer's disease.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global active pharmaceutical ingredient (API) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Dr. Reddy's Laboratories Ltd., Novartis AG, Mylan N.V., Amneal Pharmaceuticals LLC, Lonza Group, Lupin Limited, Fresenius Kabi, Hikma Pharmaceuticals, Cipla Limited, Glenmark Pharmaceuticals Limited, Sun Pharmaceutical Industries Ltd., Endo International plc, Aurobindo Pharma Limited, Apotex Inc, Taro Pharmaceutical Industries Ltd, Stada Arzneimittel AG, Krka Pharmaceuticals, CordenPharma International, Evonik Industries AG, and Biological E. Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global active pharmaceutical ingredient (API) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global active pharmaceutical ingredient (API) market

Market Segmentation

Global Active Pharmaceutical Ingredient (API) Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
Low Potent APIs
High Potent APIs
Global Active Pharmaceutical Ingredient (API) Market, By Molecular Type (Revenue, USD Bn, 2021 - 2033)
Small Molecules
Large Molecules
Global Active Pharmaceutical Ingredient (API) Market, By Formulation (Revenue, USD Bn, 2021 - 2033)
Oral
Topical
Injectable
Drops
Global Active Pharmaceutical Ingredient (API) Market, By Application (Revenue, USD Bn, 2021 - 2033)
Diabetes
Oncology
Cardiovascular
CNS
Analgesics
Ophthalmic
Respiratory
Dermatology
Others
Global Active Pharmaceutical Ingredient (API) Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
Teva Pharmaceutical Industries Ltd.
Pfizer, Inc.
Reddy's Laboratories Ltd.
Novartis AG
Mylan N.V.
Amneal Pharmaceuticals LLC
Lonza Group
Lupin Limited
Fresenius Kabi
Hikma Pharmaceuticals
Cipla Limited
Glenmark Pharmaceuticals Limited
Sun Pharmaceutical Industries Ltd.
Endo International plc
Aurobindo Pharma Limited
Apotex Inc
Taro Pharmaceutical Industries Ltd
Stada Arzneimittel AG
Krka Pharmaceuticals
CordenPharma International
Evonik Industries AG
Biological E. Limited.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Molecular Type
- Market Snippet, By Formulation
- Market Snippet, By Application
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Regulatory Scenario
Market Trends
API Patent Expiration
Production Capability Analysis
Mergers, Acquisitions and Collaboration Scenario
Key Developments
PEST Analysis
Investments & Funding
Production and Consumption Analysis

4. Global Active Pharmaceutical Ingredients (API) Market, By Product Type, 2026 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Low Potent APIs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
High Potent APIs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)

5. Global Active Pharmaceutical Ingredients (API) Market, By Molecular Type, 2026 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Small Molecules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
Large Molecules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)

6. Global Active Pharmaceutical Ingredients (API) Market, By Formulation, 2026 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)

7. Global Active Pharmaceutical Ingredients (API) Market, By Application, 2026 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
CNS
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
Ophthalmic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
Respiratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Bn)

8. Global Active Pharmaceutical Ingredients (API) Market, By Region, 2026 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2026 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2026 -2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Formulation, 2026-2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2026-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 -2033, (US$ Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2026 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2026 -2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Formulation, 2026-2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2026-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 -2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2026 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2026 -2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Formulation, 2026-2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2026-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 -2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2026 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2026 -2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Formulation, 2026-2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2026-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 -2033, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2026 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2026 -2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Formulation, 2026-2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2026-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2026 -2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Product Type, 2026 -2033, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Molecular Type, 2026 -2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Formulation, 2026-2033, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2026-2033, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2026 -2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Teva Pharmaceutical Industries Ltd
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Pfizer, Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Dr. Reddy's Laboratories Ltd
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Novartis AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Mylan N.V.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Amneal Pharmaceuticals LLC
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Lonza Group
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Lupin Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Fresenius Kabi
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Hikma Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Cipla Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Glenmark Pharmaceuticals Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Sun Pharmaceutical Industries Ltd
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Endo International plc
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Aurobindo Pharma Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Apotex Inc.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Taro Pharmaceutical Industries Ltd
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Stada Arzneimittel AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Krka Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- CordenPharma International
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Evonik Industries AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Biological E. Limited
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies